Last reviewed · How we verify
Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine (Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine) — U.S. Army Medical Research and Development Command.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine TARGET | Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine | U.S. Army Medical Research and Development Command | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine CI watch — RSS
- Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine CI watch — Atom
- Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine CI watch — JSON
- Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/varicella-vaccine-and-haemophilus-influenzae-type-b-conjugate-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab